KFDA to designate bioequivalence centers

Published: 2007-03-14 06:59:00

Updated: 2007-03-14 06:59:00

The Korea Food and Drug Administration said on March 12 it plans to enact a bill to legislate the designation of new biocenters from July next year, as part of its effort to ensure the reliability of bioequivalence test results and to lift the level of bioequivalence centers to that of the advanc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK